BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao R, Liu J, Li Z, Zhang W, Wang F, Zhang B. Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy. Pharmaceutics 2022;14:1541. [PMID: 35893797 DOI: 10.3390/pharmaceutics14081541] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Gargiulo E, Giordano M, Niemann CU, Moussay E, Paggetti J, Morande PE. The protective role of the microenvironment in hairy cell leukemia treatment: Facts and perspectives. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1122699] [Reference Citation Analysis]
2 Rodà F, Caraffi R, Picciolini S, Tosi G, Vandelli MA, Ruozi B, Bedoni M, Ottonelli I, Duskey JT. Recent Advances on Surface-Modified GBM Targeted Nanoparticles: Targeting Strategies and Surface Characterization. Int J Mol Sci 2023;24. [PMID: 36768820 DOI: 10.3390/ijms24032496] [Reference Citation Analysis]
3 Zhou Z, Staropoli I, Brelot A, Suzanne P, Lesnard A, Fontaine F, Perato S, Rault S, Helynck O, Arenzana-Seisdedos F, Sopkova-de Oliveira Santos J, Lagane B, Munier-Lehmann H, Colin P. Discovery of Bis-Imidazoline Derivatives as New CXCR4 Ligands. Molecules 2023;28. [PMID: 36770826 DOI: 10.3390/molecules28031156] [Reference Citation Analysis]
4 Khan SU, Khan MU, Gao Y, Khan MI, Puswal SM, Zubair M, Khan MA, Farwa R, Gao S, Ali R, Hussain N. Unique therapeutic potentialities of exosomes based nanodrug carriers to target tumor microenvironment in cancer therapy. OpenNano 2022;8:100091. [DOI: 10.1016/j.onano.2022.100091] [Reference Citation Analysis]